XJPX
7079
Market cap38mUSD
Jul 10, Last price
2,609.00JPY
1D
2.11%
1Q
-0.50%
IPO
-17.70%
Name
WDB coco Co Ltd
Chart & Performance
P/E
9.22
P/S
1.30
EPS
282.82
Div Yield, %
3.07%
Shrs. gr., 5y
0.42%
Rev. gr., 5y
13.38%
Revenues
4.82b
-9.59%
Net income
679m
-25.59%
CFO
571m
-48.33%
Dividend
Mar 30, 202695 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
WDB coco Co., Ltd. offers specialized contractual services to pharmaceutical companies throughout Japan. The firm plays a crucial role in advancing pharmaceuticals and medical devices, with a particular focus on safety information management, support for safety data systems, clinical research assistance, and post-market safety operations. Its offerings also encompass translation and quality control document preparation, additional clinical study support, and personnel dispatch. Furthermore, WDB coco provides comprehensive post-marketing surveillance (PMS) solutions, which include securing agreements with healthcare facilities, explaining survey protocols, collecting survey forms, conducting detailed monitoring (like re-surveys), managing a central case registration center, handling data, and performing statistical analyses. Established in 1984, the company's headquarters are located in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||